Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United States (U.S.) Department of Defense (DoD) for ...
SK bioscience and Sanofi have announced plans for global Phase III studies, which will assess the safety and immunogenicity ...
The Australian pig industry hopes work to develop a vaccine to protect its animals against Japanese encephalitis virus can be ...
HC Wainwright reiterated their buy rating on shares of Valneva (NASDAQ:VALN – Free Report) in a report published on Friday morning,Benzinga reports. They currently have a $18.00 price target on the ...
Valneva’s growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term ...
When her 5-year-old son’s legs stopped working and a doctor said the word “polio,” this writer felt a terror she never ...
Vaxxas has announced that the CEPI, has approved the progression of a $7.2 million program to develop heat-stable, ...
Equities researchers at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Valneva in a research note ...